PBI
63
-3
PRU
54
-2
ADSK
59
-2
EMR
60
-7
CHD
32
-3
ROP
38
-4
HON
64
-4
CAH
61
-5
CME
49
-4
AMG
75
-4
PEG
44
-4
CPB
37
-2
HBAN
74
-3
SNA
46
-6
MS
72
-2
DD
34
-4
APH
52
-4
HP
41
-3
D
38
-5
CVS
41
-2
PBI
63
-3
PRU
54
-2
ADSK
59
-2
EMR
60
-7
CHD
32
-3
ROP
38
-4
HON
64
-4
CAH
61
-5
CME
49
-4
AMG
75
-4
PEG
44
-4
CPB
37
-2
HBAN
74
-3
SNA
46
-6
MS
72
-2
DD
34
-4
APH
52
-4
HP
41
-3
D
38
-5
CVS
41
-2
Financhill
Back

Nuveen Real Estate Income Fund. Vs. Corcept Therapeutics, Inc. Industry Stock Comparison

Buy
67

JRS
Nuveen Real Estate Income Fund.

Last Price:
$7.65
Seasonality Move:
1.27%
Sell
30

CORT
Corcept Therapeutics, Inc.

Last Price:
$34.79
Seasonality Move:
13.21%
Buy
67
Nuveen Real Estate Income Fund. (JRS) is a Buy

Is Nuveen Real Estate Income Fund. a Buy, Sell or Hold?

  • The current Nuveen Real Estate Income Fund. [JRS] share price is $7.66. The Score for JRS is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
  • JRS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
30
Corcept Therapeutics, Inc. (CORT) is a Sell

Is Corcept Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Corcept Therapeutics, Inc. [CORT] share price is $34.80. The Score for CORT is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CORT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

JRS Stock Price Chart

What is Nuveen Real Estate Income Fund.'s stock price today?

  • The Nuveen Real Estate Income Fund. share price today is $7.66
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JRS is experiencing slight selling pressure.

CORT Stock Price Chart

What is Corcept Therapeutics, Inc.'s stock price today?

  • The Corcept Therapeutics, Inc. share price today is $34.80
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CORT is experiencing slight selling pressure.

JRS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.06 Sell
Relative Strength Index (14 RSI): 45.71 Sell
Chaikin Money Flow: -35678 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.6 - 7.82) Sell
Bollinger Bands (100): (7.73 - 8.13) Sell

CORT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.88 Sell
Relative Strength Index (14 RSI): 14.83 Sell
Chaikin Money Flow: -8077532 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (70.63 - 90.59) Sell
Bollinger Bands (100): (69.66 - 84.14) Sell

JRS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 7.62 Buy
20-day SMA: 7.67 Sell
50-day SMA: 7.83 Sell
200-day SMA: 7.87 Sell
8-day EMA: 7.64 Buy
20-day EMA: 7.68 Sell
50-day EMA: 7.79 Sell
200-day EMA: 7.96 Sell

CORT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 75.24 Sell
20-day SMA: 80.76 Sell
50-day SMA: 77.62 Sell
200-day SMA: 73.92 Sell
8-day EMA: 69.79 Sell
20-day EMA: 76.79 Sell
50-day EMA: 77.19 Sell
200-day EMA: 51.2 Sell

Nuveen Real Estate Income Fund. Earnings Growth & JRS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Corcept Therapeutics, Inc. Earnings Growth & CORT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.45 per share, and an increase next year of $3.04 per share.

Nuveen Real Estate Income Fund. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Corcept Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):